Chen Xiangmei

[Expert Profile] Chen Xiangmei, Chief Physician, Professor, Doctoral Supervisor, Academician of the Chinese Academy of Engineering, is an authoritative expert in nephrology in China, working in the Department of Nephrology, Chinese PLA General Hospital (301 Hospital). She has long been dedicated to clinical diagnosis, treatment, and scientific research of difficult kidney diseases, IgA nephropathy, and complex Budd-Chiari syndrome, and is an important leading figure in nephrology both domestically and internationally.

[Education & Career] Professor Chen Xiangmei graduated from a military medical university, completed systematic clinical training at the Chinese PLA General Hospital, and further studied at famous international nephrology centers. She has long served as Director of the Department of Nephrology at the Chinese PLA General Hospital and Director of the National Clinical Research Center for Kidney Diseases. She was elected as an Academician of the Chinese Academy of Engineering in 2007, and has held important academic positions including Chair of the Nephrology Branch of the Chinese Medical Association. She is an academic leader in the field of nephrology in China.

[Areas of Expertise] Professor Chen specializes in the diagnosis and treatment of various difficult glomerular diseases such as IgA nephropathy and membranous nephropathy, as well as comprehensive management of difficult renal vascular diseases such as complex Budd-Chiari syndrome. She has profound expertise in precise renal biopsy pathological diagnosis, standardized application of immunosuppressive therapy and novel targeted drugs, and whole-course management of chronic kidney disease. She excels at managing difficult kidney disease cases of "proteinuria, recurrent hematuria, and progressive decline in renal function," helping numerous patients slow the progression of renal failure and protect kidney function.

[Academic Achievements & Industry Contributions] Professor Chen has led the establishment of a large Chinese IgA nephropathy clinical cohort, first systematically elucidating the clinicopathological characteristics and prognostic factors of IgA nephropathy in Chinese populations, led the development of Chinese IgA nephropathy and chronic kidney disease diagnosis and treatment guidelines and expert consensus statements, and promoted the establishment of China's chronic kidney disease prevention and treatment system. She has presided over major national projects including the National "973" Program and Key R&D Program, with findings published in top international journals and receiving multiple National Science and Technology Progress Awards, making foundational contributions to the development of nephrology in China.

[Clinical Practice & Outstanding Contributions] For decades on the front lines of nephrology, Professor Chen has treated tens of thousands of patients with various kidney diseases, leading her team in successfully managing numerous difficult critical kidney disease patients. She has actively participated in national healthcare and major tasks, and has been repeatedly recognized as a national advanced worker. She has trained a large number of nephrology leaders, and is a truly deserving authority in the field of nephrology in China, deeply admired by patients and peers alike.

[Honors & Reputation] Professor Chen Xiangmei serves as Director of the Department of Nephrology at the Chinese PLA General Hospital, Director of the National Clinical Research Center for Kidney Diseases, and Chair of the Nephrology Branch of the Chinese Medical Association, among other academic positions. She was elected as an Academician of the Chinese Academy of Engineering in 2007, has presided over national-level major projects including the National "973" Program and Key R&D Program, and is an authoritative expert in the field of nephrology in China. She has led the establishment of a large Chinese IgA nephropathy clinical cohort, led the development of Chinese IgA nephropathy and chronic kidney disease diagnosis and treatment guidelines, promoted the construction of China's chronic kidney disease prevention and treatment system, with findings published in top international journals and receiving multiple National Science and Technology Progress Awards. She has trained a large number of nephrology leaders, and is deeply trusted by patients and respected by peers alike. She is a pillar of the field of nephrology in China.